Sanofi has entered into an agreement to acquire Vicebio Ltd, a privately held biotechnology company headquartered in Lon...
Over the last 50 years, Switzerland has emerged as one of the most innovative and collaborative biotech hubs in the worl...
South Korea-based biopharmaceutical company Samsung Bioepis has published a whitepaper titled ‘Solving the Biosimi...
China-based CStone Pharmaceuticals has announced an exclusive partnership with Istituto Gentili, a leading European biop...
Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, and Sensible Biotechno...
Haleon, a global leader in consumer health and maker of leading brands such as Sensodyne, parodontax and Polident, broke...
Portal Biotech, a pioneering biotechnology company headquartered in London, has secured $35 million in Series A funding,...
Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK, reinforcing the comp...
Cytiva, a Danaher company and global life sciences leader, has completed significant expansion projects in several locat...
Syensqo, a global leader in advanced materials and specialty chemicals, has announced the inauguration of its world clas...
Netherlands-based holding company Qiagen N.V. has announced the expansion of its oncology diagnostics portfolio with two...
French pharmaceutical company Sanofi and Blueprint Medicines Corporation, a US-based, publicly traded biopharmaceutical ...
As the field shifts toward safer and more efficient gene delivery methods, PlasmidFactory’s proprietary technology...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Adalvo Limited in the Europe...
Sanofi and Vietnam Vaccine JSC, or VNVC, launched a project on 27 May to establish vaccine manufacturing facility in...
Qiagen has announced a new commercial partnership and co-marketing agreement with ID Solutions, a French provider of hig...
Ireland-headquartered Medtronic plc, a global leader in healthcare technology, has announced its intent to separate its ...
China-based WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has ...
